IDA
NVO

Intelligence Driven Advisers’s Novo Nordisk NVO Stock Holding History

Intelligence Driven Advisers’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,571
Closed -$330K – 115
2024
Q1 		$330K Sell
2,571
-2,095
-45% -$249K 0.05% 68
2023
Q4 		$535K Buy
4,666
+762
+20% +$75.4K 0.09% 49
2023
Q3 		$348K Buy
3,904
+454
+13% +$40K 0.06% 60
2023
Q2 		$273K Sell
3,450
-16
-0.5% -$1.31K 0.05% 77
2023
Q1 		$274K Buy
3,466
+6
+0.2% +$425 0.05% 74
2022
Q4 		$240K Sell
3,460
-380
-10% -$22.3K 0.04% 85
2022
Q3 		$203K Buy
+3,840
New +$206K 0.04% 106

Other funds holding NVO

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Intelligence Driven Advisers's NVO Position: Q2 2024 in Review

Intelligence Driven Advisers sold out of Novo Nordisk (NVO) in Q2 2024, closing a stake of 2,571 shares — an estimated $330K sold.

Intelligence Driven Advisers first reported a position in NVO in Q3 2022 and held it in 7 quarters. The position peaked at $535K in Q4 2023. 1,864 funds tracked by Wall St. Rank hold NVO as of Q2 2024.

  • Intelligence Driven Advisers reported no remaining Novo Nordisk position as of Q2 2024 after selling out during the quarter.
  • Intelligence Driven Advisers sold 2,571 Novo Nordisk shares in Q2 2024, an estimated $330K.
  • Intelligence Driven Advisers first reported a position in Novo Nordisk in Q3 2022 and held it in 7 quarters.
  • Intelligence Driven Advisers's Novo Nordisk position peaked at $535K in Q4 2023.
  • 1,864 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2024.

Based on Intelligence Driven Advisers's 13F filing for Q2 2024, filed 5 Aug 2024.